BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

 

The FDA Will Re-Examine Bexxar

CME TELEMETRIX ANNOUNCES NON-INVASIVE MEASUREMENT CAPABILITY FOR HbA1c AT ANNUAL MEETING OF SHAREHOLDERS

CME TELEMETRIX ANNOUNCES SENIOR MANAGEMENT CHANGE

A Statin A Day Keeps the Doctor Away

Inactivation of highly infectious materials 

Molecular Classification of Disease

Setback for Vevesca Approval

DNAPrint to Present RETINOME Launch and Other Advancements at Upcoming Conferences

Xolair Approved in Australia

Prestigious Award for Innate Pharma's David Raulet

Kirchhoff Consult AG (DE) - Royalty Pharma AG decides not to proceed with its initial public offering on SWX Swiss Exchange

Hemosol Receives Key U.S. Patent Approval

Cellomics - New software suite enhances cellular-based drug discovery …

Btech Weekly Report: Novel Aspects Of Diabetes Care

RiboTargets Listed by Tornado Insider as one of Europe’s Top 100 Start-Ups

Highlights of the American Diabetes Association Meeting

RiboTargets Opens Structural Biology Unit in York

Btech weekly report: Therapies for rheumatoid arthritis and psoriasis

Perkinelmer presented Frost & Sullivan award for protein array product line strategy

PerkinElmer wins Connecticut quality improvement award

Show Off Your Best Image In the Bio-Rad Laser Scanning Microscopy Image Competition

World's Largest Biomanufacturing Facility For Seed Potato To Be Built In Wisconsin

Biogen Receives Complete Response Letter For Amevive

The Automation Partnership Launches New Cell Culture System at MipTec

Next generation microplate reader …

Tecan's new website goes live ...

Northview Biosciences Forms West Coast Incubator 

Will GM rice lead the way for global acceptance of GM crop technology? New consultancy report now available

Ghrelin: The future of obesity therapeutics? 

TKT's Progress At Replacing an Intracellular Enzyme

Summary of European LRIG Meeting Programme

Sanger Institute Plays Host to Successful Laboratory Meeting

IDEC (NASDAQ: DPH) has halted clinical trials of its therapeutic monoclonal antibody IDEC-131 

Btech Weekly Report: Scientific Advances In RNA Interference and Cloning

Btech Report: Biotechnology Industry Valuation

Molecular Devices Announces Acquisition of Universal Imaging Corporation

Rad Bioscience Wins Israel’s Biotechnology Incubator Competition

Tracleer Efficacious in Children for treatment of pulmonary arterial hypertension (PAH)

Platform Technology vs. Drug Discovery

Kirchhoff Consult AG (DE) - Royalty Pharma AG announces IPO

Bayer Chooses Empliant to Support Acquisition of Aventis CropSciences

PERKINELMER LIFE SCIENCES DISCLOSES DETAILS OF NEW PROTEINARRAY WORKSTATION

Paul Lucas Elected to Board of Directors at Tm Bioscience

Recommendations Should Lead to Increased Aranesp and Neulasta sales in Europe

Treating Erectile Dysfunction

Rad Bioscience Wins Israel’s Biotechnology Incubator Competition

Tracleer Efficacious in Children for treatment of pulmonary arterial hypertension (PAH)

Platform Technology vs. Drug Discovery

Kirchhoff Consult AG (DE) - Royalty Pharma AG announces IPO

Bayer Chooses Empliant to Support Acquisition of Aventis CropSciences

Tm Bioscience to Hold Annual General Meeting of Shareholders

PERKINELMER LIFE SCIENCES DISCLOSES DETAILS OF NEW PROTEINARRAY WORKSTATION

Paul Lucas Elected to Board of Directors at Tm Bioscience

Recommendations Should Lead to Increased Aranesp and Neulasta sales in Europe

Treating Erectile Dysfunction

 
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.